Compare BYD & GRFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BYD | GRFS |
|---|---|---|
| Founded | 1973 | 1940 |
| Country | United States | Spain |
| Employees | N/A | 25247 |
| Industry | Hotels/Resorts | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.7B | 5.5B |
| IPO Year | 1996 | N/A |
| Metric | BYD | GRFS |
|---|---|---|
| Price | $89.29 | $7.96 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 11 | 2 |
| Target Price | ★ $91.00 | $10.15 |
| AVG Volume (30 Days) | ★ 660.9K | 639.3K |
| Earning Date | 04-23-2026 | 07-28-2022 |
| Dividend Yield | 0.84% | ★ 1.70% |
| EPS Growth | ★ 264.46 | N/A |
| EPS | ★ 22.56 | N/A |
| Revenue | ★ $2,626,730,000.00 | N/A |
| Revenue This Year | $1.71 | $4.49 |
| Revenue Next Year | $2.74 | $6.42 |
| P/E Ratio | ★ $3.80 | $18.67 |
| Revenue Growth | ★ 9.41 | N/A |
| 52 Week Low | $67.67 | $6.90 |
| 52 Week High | $89.96 | $11.14 |
| Indicator | BYD | GRFS |
|---|---|---|
| Relative Strength Index (RSI) | 61.19 | 42.52 |
| Support Level | $80.53 | $7.52 |
| Resistance Level | N/A | $9.78 |
| Average True Range (ATR) | 2.00 | 0.21 |
| MACD | 0.26 | 0.01 |
| Stochastic Oscillator | 98.22 | 12.37 |
Boyd Gaming Corp is a multi-jurisdictional gaming company. The company operates wholly-owned gaming entertainment properties (casino space, slot machines, table games, and hotel rooms) in Nevada, Illinois, Indiana, Iowa, Kansas, Louisiana, Mississippi, Missouri, Ohio, and Pennsylvania. Geographical regions separate its business segments: Las Vegas Locals, Downtown Las Vegas, Midwest and South, and Online. Midwest and South hold the key number of entertainment properties, and it generate the majority of sales for the company.
Grifols SA one of is global specialty plasma therapeutics companies developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins. Plasma derivatives are proteins found in human plasma, which once isolated and purified, have therapeutic value. These protein-based therapies extend and enhance the lives of individuals who suffer from chronic and acute, often life-threatening, conditions, including primary and secondary immunological deficiencies, Chronic Inflammatory Demyelinating Polyneuropathy, immune-mediated ITP. Products and services are used to diagnose and treat patients with hemophilia, immune deficiencies, infectious diseases and a range of other medical conditions. Majority of revenue is from USA.